Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German ...

Pallas Capital Advisors LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 59.4% during the fourth quarter, according to its most recent 13F filing with the Securities ...

Tilray Brands (NASDAQ: TLRY) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report. Heading into the news, Wall Street analysts anticipated ...

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe ...

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to break-even earnings per share a year ago.

For the quarter ended November 2024, Tilray Brands, Inc. (TLRY) reported revenue of $210.95 million, up 8.9% over the same period last year. EPS came in at -$0.10, compared to $0.00 in the year ...

Inc. (TLRY) reached $1.45, with a -0.68% movement compared to the previous day. This change lagged the S&P 500's 1.26% gain on the day. Elsewhere, the Dow gained 0.8%, while the tech-heavy Nasdaq ...

Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) dropped 4.1% during mid-day trading on Monday following a weaker than expected earnings announcement. The stock traded as low as $1.16 and last ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 13.5% in the morning session after the company reported ...